Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors

Circulation. 2008 Sep 16;118(12):1285-93. doi: 10.1161/CIRCULATIONAHA.107.760892.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Atrial Fibrillation / enzymology*
  • Atrial Fibrillation / prevention & control*
  • Clinical Trials as Topic / methods
  • Humans
  • Hydroxymethylglutaryl CoA Reductases / metabolism
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hydroxymethylglutaryl CoA Reductases